QA: Evofem Biosciences Inc in us_pharma/2025

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001618835_2026_Evofem_Biosciences_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001618835, Evofem Biosciences Inc

  xvar xval
0 AssetsCurrent 15,284,000
1 IntangibleAssetsNetIncludingGoodwill 4,348,000
2 PropertyPlantAndEquipmentNet 418,000
3 remainder_Assets 224,000
4 LiabilitiesCurrent 84,820,000
5 LiabilitiesNoncurrent 54,000
6 remainder_Liabilities 4,837,000
7 CostOfGoodsAndServicesSold 4,488,993
8 SellingGeneralAndAdministrativeExpense 7,457,750
9 ResearchAndDevelopmentExpense 378,969
10 remainder_Expenses 5,946,487
11 remainder_Revenues 21,269,862
12 remainder_NetIncome -2,721,569
13 remainder_ComprehensiveNetIncome -4,263,196
  yvar yval
0 Assets 20,274,000
1 Liabilities 89,711,000
2 Expenses 18,272,199
3 Revenues 21,269,862
4 StockholdersEquity -69,437,000
5 NetIncome 276,094
6 ComprehensiveNetIncome -1,855,504
7 BaseVar 78,255,913
8 EconomicCapitalRatiobeforeLimitedLiability -2.79
9 EconomicCapitalRatio 0.758

Edgar->Model Mapping

Feature Distribution

Change over Time